A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer.

Cancer Lett

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address:

Published: April 2024

AI Article Synopsis

  • Cancer remains a significant global healthcare issue, emphasizing the importance of early diagnosis, but existing miRNA-based diagnostic methods face limitations due to unclear cutoff values.
  • Researchers developed a new diagnostic method using machine learning to evaluate the expression of specific miRNAs (called miRPs) in over 15,000 patients across different cancer types, identifying the most effective machine-learning algorithm (Random Forest) with 31 targeted miRPs.
  • The new 31-miRP model demonstrated exceptional performance in identifying cancers, especially in early stages, achieving high accuracy rates (AUC between 0.980-1.000) and outperforming other previously published diagnostic signatures.

Article Abstract

Cancer remains a major burden globally and the critical role of early diagnosis is self-evident. Although various miRNA-based signatures have been developed in past decades, clinical utilization is limited due to a lack of precise cutoff value. Here, we innovatively developed a signature based on pairwise expression of miRNAs (miRPs) for pan-cancer diagnosis using machine learning approach. We analyzed miRNA spectrum of 15832 patients, who were divided into training, validation, test, and external test sets, with 13 different cancers from 10 cohorts. Five different machine-learning (ML) algorithms (XGBoost, SVM, RandomForest, LASSO, and Logistic) were adopted for signature construction. The best ML algorithm and the optimal number of miRPs included were identified using area under the curve (AUC) and youden index in validation set. The AUC of the best model was compared to previously published 25 signatures. Overall, Random Forest approach including 31 miRPs (31-miRP) was developed, proving highly efficient in cancer diagnosis across different datasets and cancer types (AUC range: 0.980-1.000). Regarding diagnosis of cancers at early stage, 31-miRP also exhibited high capacities, with AUC ranging from 0.961 to 0.998. Moreover, 31-miRP exhibited advantages in differentiating cancers from normal tissues (AUC range: 0.976-0.998) as well as differentiating cancers from corresponding benign lesions. Encouragingly, comparing to previously published 25 different signatures, 31-miRP also demonstrated clear advantages. In conclusion, 31-miRP acts as a powerful model for cancer diagnosis, characterized by high specificity and sensitivity as well as a clear cutoff value, thereby holding potential as a reliable tool for cancer diagnosis at early stage.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2024.216655DOI Listing

Publication Analysis

Top Keywords

cancer diagnosis
12
early diagnosis
8
published signatures
8
auc range
8
early stage
8
31-mirp exhibited
8
differentiating cancers
8
diagnosis
7
cancer
5
auc
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!